Novel HER2 Aptamer Selectively Delivers Cytotoxic Drug to HER2-positive Breast Cancer Cells in Vitro

BACKGROUND: Aptamer-based tumor targeted drug delivery system is a promising approach that may increase the efficacy of chemotherapy and reduce the related toxicity. HER2 protein is an attractive target for tumor-specific drug delivery because of its overexpression in multiple malignancies, includin...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhe, Duan, Jin-Hong, Song, Yong-Mei, Ma, Jie, Wang, Feng-Dan, Lu, Xin, Yang, Xian-Da
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583217/
https://www.ncbi.nlm.nih.gov/pubmed/22817844
http://dx.doi.org/10.1186/1479-5876-10-148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583217/
https://www.ncbi.nlm.nih.gov/pubmed/22817844
http://dx.doi.org/10.1186/1479-5876-10-148

Ejemplares similares